According to its pathological characteristics, breast cancer has been categorized into three different subtypes: estrogen receptor (ER)/progesterone receptor (PR) overexpression, epidermal growth factor receptor 2 (HER2) overexpression and triple negative breast cancer (negative for all three receptors) [2–4]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.